Dupilumab treatment in atopic dermatitis patients in the Netherlands versus Japan: a comparative cohort study revealing a discrepancy in patient-reported outcome measures

CONCLUSION: Dupilumab showed significant, comparable, and sustained improvement of EASI scores in Japanese and Dutch patients. However, we found striking differences in the effect on PROMs between the countries, with a better outcome in Japanese patients.PMID:33657668 | DOI:10.1111/bjd.19897

Source: The British Journal of Dermatology - March 3, 2021 Category: Dermatology Authors: L E M de Wijs R F T Fujimoto E R Andrinopoulou T E C Nijsten D Hijnen Y Kataoka Source Type: research